Pre clinical and Clinical evaluation of KARAPPAN CHOORANAM (oral administration) and ERULI ENNAI (external application) in the management of Atopic dermatitis
Phase 2
Completed
- Conditions
- Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
- Registration Number
- CTRI/2022/03/040769
- Lead Sponsor
- Dr Rajeetha Miraaj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Frequent focusing for skin allergy
Severe itching in skin
Erythema in skin
Vesicles in skin
Oozing in skin
Exclusion Criteria
Children above 12 years
Children below 3 years
exacerbation of eczema
eczema associated with systemic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study will help to understand the effects of KARAPPAN CHOORANAM and ERULI ENNAI in the management of PITHA KARAPPAN and may provide a better improvement in health care of children <br/ ><br> <br/ ><br>Timepoint: 15 days <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil